Home Cart Sign in  
Chemical Structure| 1872382-47-2 Chemical Structure| 1872382-47-2

Structure of UNC3866
CAS No.: 1872382-47-2

Chemical Structure| 1872382-47-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

UNC3866 is a high-affinity CBX4 and CBX7 inhibitor with Ki values of 94 and 97 nM, respectively.

Synonyms: UNC3866

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of UNC3866

CAS No. :1872382-47-2
Formula : C43H66N6O8
M.W : 795.02
SMILES Code : O=C(OC)[C@H](CO)NC([C@H](CCCCN(CC)CC)NC([C@H](CC(C)C)NC([C@H](C)NC([C@H](CC1=CC=CC=C1)NC(C2=CC=C(C(C)(C)C)C=C2)=O)=O)=O)=O)=O
Synonyms :
UNC3866
MDL No. :MFCD30536205
InChI Key :UMRRDXVUROEIKJ-JCXBGQGISA-N
Pubchem ID :101043861

Safety of UNC3866

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of UNC3866

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
PC3 prostate cancer cells 30 µM 24 hours Evaluate the intracellular accumulation of UNC3866, showing an intracellular concentration of 1.4 ± 0.3 μM Nat Chem Biol. 2016 Mar;12(3):180-7
HEK293T cells 100 µM 48 hours Evaluate the cytotoxicity of UNC3866, showing no toxicity at 100 μM Nat Chem Biol. 2016 Mar;12(3):180-7
OVCAR3 cells 40 µM 72 hours UNC3866 significantly reduced RAD51 foci formation (similar to ATM inhibition). Cancers (Basel). 2024 Jun 6;16(11):2155
U2OS cells 20 µM 72 hours UNC3866 significantly reduced IR-induced RPA1 foci formation, indicating decreased DNA end resection activity. Cancers (Basel). 2024 Jun 6;16(11):2155

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice Huh7-SR xenograft model Intraperitoneal injection 10 mg/kg Every 2 days for 2 weeks UNC3866 significantly inhibits Huh7-SR tumor growth, with enhanced effect when combined with YAP1 inhibitor CA3 Br J Cancer. 2021 Mar;124(7):1237-1248

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.26mL

0.25mL

0.13mL

6.29mL

1.26mL

0.63mL

12.58mL

2.52mL

1.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories